Diagnosis of Helicobacter pylori‐induced gastritis by serum pepsinogen levels
Authors:
- 14 May 2015
- journal article
- research article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 30 (10) , 1473-1477
Abstract
Background and Aim: Gastric cancer develops due to atrophic gastritis induced by Helicobacter pylori (H. pylori) infection. Serum levels of pepsinogen (PG) are known to be excellent markers for evaluating the degree of atrophic gastritis. We investigated whether chronic gastritis could be diagnosed by evaluating serum PG levels.Methods: A total of 4483 patients (average age, 49.7 years; 2879 men) were included in this study. Fasting serum samples were collected and anti‐H. pylori antibody and PG levels were evaluated. We evaluated the endoscopic atrophy grade or histological extent of gastritis, and calculated the diagnostic capability of this serum marker.Results: A total of 4483 patients, were diagnosed as being positive (4160) or negative (323) for H. pylori‐induced gastritis. In patients with H. pylori‐induced gastritis, the PG II levels were higher and the PG I/II ratios were lower than among those without H. pylori gastritis. A cut‐off values of (i) PG I/II ≤ 5; (ii) PG II ≥ 10 or PG I/II ≤ 5; (iii) PG II ≥ 12 or PG I/II ≤ 4.5 showed high sensitivity and accuracy (over 90%) for diagnosing H. pylori‐induced gastritis. Moreover, in a mass screening of healthy subjects, a cut‐off value of PG I/II ≤ 4.5 might be better for diagnosing the presence of gastritis because of a sensitivity and specificity > 80%.Conclusions: The presence of H. pylori‐induced gastritis can be evaluated using serum PG levels.Keywords
This publication has 19 references indexed in Scilit:
- Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in JapanJournal of Gastroenterology, 2013
- A new approach for elimination of gastric cancer deaths in JapanInternational Journal of Cancer, 2012
- Low Prevalence of Helicobacter pylori-negative Gastric Cancer among JapaneseHelicobacter, 2011
- Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised EditionHelicobacter, 2010
- Meta-analysis: Can Helicobacter pylori Eradication Treatment Reduce the Risk for Gastric Cancer?Annals of Internal Medicine, 2009
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008
- Gastric cancer screening using the serum pepsinogen test methodGastric Cancer, 2006
- Biomarkers in Patients with Gastric Inflammation: A Systematic ReviewDigestion, 2005
- Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levelsJournal of Gastroenterology, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001